Close Menu

NEW YORK (360Dx) – Avant Diagnostics on Wednesday said it has acquired an exclusive option to license Genetic Health Solution's patient-delivery technology platform.

Avant said it plans to use the platform to develop a personalized cancer patient management program that will combine blood biomarker monitoring and drug side effect profiles to help reduce negative drug side effects in cancer patients.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Apr
29
Sponsored by
Co-Diagnostics

Join Dr. Heather Fehling, Chief Scientific Officer at Clinical Reference Labs (CRL), as she provides some insights regarding the future applications of PCR testing.